Global serum glycoform profiling for the investigation of dystroglycanopathies & Congenital Disorders of Glycosylation

Molecular Genetics and Metabolism Reports

Volumn 7, Issue , 2016, Pages 55-62

  Heywood, Wendy E ^a,b   Bliss, Emily ^a,b   Mills, Philippa ^a,b   Yuzugulen, Jale ^a   Carreno, Gabriela ^a   Clayton, Peter T ^a,b   Muntoni, Francesco ^b   Worthington, Viki C ^c   Torelli, Silvia ^b   Sebire, Neil J ^a   Mills, Kevin ^a,b   Grunewald, Stephanie ^a,b  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

C1 esterase inhibitor; Congenital Disorders of Glycosylation; Dystroglycanopathies, 2D DIGE; Glycoproteome; Antitrypsin

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; CERULOPLASMIN; COMPLEMENT COMPONENT C1S INHIBITOR; FETUIN A; OROSOMUCOID;

ARTICLE; CONGENITAL DISORDER OF GLYCOSYLATION; CONTROLLED STUDY; DYSTROGLYCANOPATHY; HUMAN; ISOELECTRIC FOCUSING; MOLECULAR WEIGHT; MUSCULAR DYSTROPHY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN GLYCOSYLATION; PROTEOMICS; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 84963701092     PISSN: None     EISSN: 22144269     Source Type: Journal    
DOI: 10.1016/j.ymgmr.2016.03.002     Document Type: Article

References (32)

1. J. Jaeken Congenital disorders of glycosylation (CDG): it's (nearly) all in it! J. Inherit. Metab. Dis. 34 4 2011 853 858
2. M. Theodore, and E. Morava Congenital disorders of glycosylation: sweet news Curr. Opin. Pediatr. 23 6 2011 581 587
3. R. Barone, L. Sturiale, A. Palmigiano, M. Zappia, and D. Garozzo Glycomics of pediatric and adulthood diseases of the central nervous system J. Proteomics 75 17 2012 5123 5139
4. J. Jaeken, T. Hennet, G. Matthijs, and H.H. Freeze CDG nomenclature: time for a change! Biochim. Biophys. Acta. 1792 9 2009 825 826
5. J. Jaeken Congenital disorders of glycosylation Ann. NY. Acad. Sci. 1214 2010 190 198
6. R. Zeevaert, F. Foulquier, J. Jaeken, and G. Matthijs Deficiencies in subunits of the conserved oligomeric golgi (COG) complex define a novel group of congenital disorders of glycosylation Mol. Genet. Metab. 93 1 2008 15 21
7. S. Wopereis, D.J. Lefeber, E. Morava, and R.A. Wevers Mechanisms in protein O-glycan biosynthesis and clinical and molecular aspects of protein O-glycan biosynthesis defects: a review Clin. Chem. 52 4 2006 574 600
8. T. Hennet Diseases of glycosylation beyond classical congenital disorders of glycosylation Biochim. Biophys. Acta. 1820 9 2012 1306 1317
9. C. Godfrey, A.R. Foley, E. Clement, and F. Muntoni Dystroglycanopathies: coming into focus Curr. Opin. Genet. Dev. 21 3 2011 278 285
10. L. Wells The O-mannosylation pathway: glycosyltransferases and proteins implicated in congenital muscular dystrophy J. Biol. Chem. 288 10 2013 6930 6935
11. T. Willer, H. Lee, M. Lommel, T. Yoshida-Moriguchi, D.B. de Bernabe, D. Venzke, and et al. ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome Nat. Genet. 44 5 2012 575 580
12. D.J. Lefeber, J. Schonberger, E. Morava, M. Guillard, K.M. Huyben, K. Verrijp, and et al. Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies Am. J. Hum. Genet. 85 1 2009 76 86
13. K.J. Carss, E. Stevens, A.R. Foley, S. Cirak, M. Riemersma, S. Torelli, and et al. Mutations in GDP-mannose pyrophosphorylase B Cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of alpha-dystroglycan Am. J. Hum. Genet. 93 1 2013 29 41
14. J. van Reeuwijk, M. Janssen, C. van den Elzen, B.D. Beltran-Valero de, P. Sabatelli, L. Merlini, and et al. POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome J. Med. Genet. 42 12 2005 907 912
15. S. Wopereis, S. Grunewald, K.M. Huijben, E. Morava, R. Mollicone, B.G. van Engelen, and et al. Transferrin and apolipoprotein C-III isofocusing are complementary in the diagnosis of N- and O-glycan biosynthesis defects Clin. Chem. 53 2 2007 180 187
16. E. Quintana, S. Gala, A. Garcia-Cazorla, R. Montero, C. Munoz-Almagro, M.A. Vilaseca, and et al. Secondary alteration of the transferrin isoelectric focusing pattern in a case of bacterial meningitis J. Inherit. Metab. Dis. 30 2 2007 267
17. P. Mills, K. Mills, P. Clayton, A. Johnson, D. Whitehouse, and B. Winchester Congenital disorders of glycosylation type I leads to altered processing of N-linked glycans, as well as underglycosylation Biochem. J. 359 Pt 2 2001 249 254
18. W.E. Heywood, T.E. Madgett, D. Wang, A. Wallington, J. Hogg, K. Mills, and et al. 2D DIGE analysis of maternal plasma for potential biomarkers of Down Syndrome Proteome. Sci. 9 2011 56
19. K. Mills, P.B. Mills, P.T. Clayton, A.W. Johnson, D.B. Whitehouse, and B.G. Winchester Identification of alpha(1)-antitrypsin variants in plasma with the use of proteomic technology Clin. Chem. 47 11 2001 2012 2022
20. A. Shevchenko, M. Wilm, O. Vorm, and M. Mann Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels Anal. Chem. 68 5 1996 850 858
21. W. Heywood, K. Mills, D. Wang, J. Hogg, T.E. Madgett, N.D. Avent, and et al. Identification of new biomarkers for Down's syndrome in maternal plasma J. Proteome 75 9 2012 2621 2628
22. B.G. Ng, K.J. Buckingham, K. Raymond, M. Kircher, E.H. Turner, M. He, and et al. Mosaicism of the UDP-galactose transporter SLC35A2 causes a congenital disorder of glycosylation Am. J. Hum. Genet. 92 4 2013 632 636
23. V. Hucthagowder, E. Morava, U. Kornak, D.J. Lefeber, B. Fischer, A. Dimopoulou, and et al. Loss-of-function mutations in ATP6V0A2 impair vesicular trafficking, tropoelastin secretion and cell survival Hum. Mol. Genet. 18 12 2009 2149 2165
24. D. Rymen, R. Peanne, M.B. Millon, V. Race, L. Sturiale, D. Garozzo, and et al. MAN1B1 deficiency: an unexpected CDG-II PLoS Genet. 9 12 2013 e1003989
25. J.T. Aguilan, S. Sundaram, E. Nieves, and P. Stanley Mutational and functional analysis of large in a novel CHO glycosylation mutant Glycobiology 19 9 2009 971 986
26. S.K. Patnaik, and P. Stanley Mouse large can modify complex N- and mucin O-glycans on alpha-dystroglycan to induce laminin binding J. Biol. Chem. 280 21 2005 20851 20859
27. T. Yoshida-Moriguchi, T. Willer, M.E. Anderson, D. Venzke, T. Whyte, F. Muntoni, and et al. SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function Science 341 6148 2013 896 899
28. N. Callewaert, E. Schollen, A. Vanhecke, J. Jaeken, G. Matthijs, and R. Contreras Increased fucosylation and reduced branching of serum glycoprotein N-glycans in all known subtypes of congenital disorder of glycosylation I Glycobiology 13 5 2003 367 375
29. P.B. Mills, K. Mills, N. Mian, B.G. Winchester, and P.T. Clayton Mass spectrometric analysis of glycans in elucidating the pathogenesis of CDG type IIx J. Inherit. Metab. Dis. 26 2-3 2003 119 134
30. W.E. Heywood, P. Mills, S. Grunewald, V. Worthington, J. Jaeken, G. Carreno, and et al. A new method for the rapid diagnosis of protein N-linked congenital disorders of glycosylation J. Proteome. Res. 12 7 2013 3471 3479
31. R.J. Chalkley, A. Thalhammer, R. Schoepfer, and A.L. Burlingame Identification of protein O-GlcNAcylation sites using electron transfer dissociation mass spectrometry on native peptides Proc. Natl. Acad. Sci. U S A 106 22 2009 8894 8899
32. K. Scott, T. Gadomski, T. Kozicz, and E. Morava Congenital disorders of glycosylation: new defects and still counting J. Inherit. Metab. Dis. 37 4 2014 609 617